JMPWA
PLRX icon

JP Morgan Private Wealth Advisors’s Pliant Therapeutics PLRX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,384
Closed -$250K – 1802
2023
Q1 		$250K Buy
+9,384
New +$267K ﹤0.01% 1747

Other funds holding PLRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PLRX Position: Q2 2023 in Review

JP Morgan Private Wealth Advisors sold out of Pliant Therapeutics (PLRX) in Q2 2023, closing a stake of 9,384 shares — an estimated $250K sold.

JP Morgan Private Wealth Advisors first reported a position in PLRX in Q1 2023 and held it in 1 quarter. The position peaked at $250K in Q1 2023. 144 funds tracked by Wall St. Rank hold PLRX as of Q2 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Pliant Therapeutics position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 9,384 Pliant Therapeutics shares in Q2 2023, an estimated $250K.
  • JP Morgan Private Wealth Advisors first reported a position in Pliant Therapeutics in Q1 2023 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Pliant Therapeutics position peaked at $250K in Q1 2023.
  • 144 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.